Sectra AB (publ) (SECT-B.ST)
SEK 274.3
(0.94%)
SEK 274.3
(0.94%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.96 Billion SEK | 26.07% |
| 2022 | 2.35 Billion SEK | 20.6% |
| 2021 | 1.94 Billion SEK | 19.4% |
| 2020 | 1.63 Billion SEK | -1.73% |
| 2019 | 1.66 Billion SEK | 17.52% |
| 2018 | 1.41 Billion SEK | 11.61% |
| 2017 | 1.26 Billion SEK | 11.01% |
| 2016 | 1.14 Billion SEK | 6.27% |
| 2015 | 1.07 Billion SEK | 11.67% |
| 2014 | 961.39 Million SEK | 12.6% |
| 2013 | 853.79 Million SEK | 4.51% |
| 2012 | 816.95 Million SEK | -0.75% |
| 2011 | 823.09 Million SEK | -9.64% |
| 2010 | 910.88 Million SEK | 5.37% |
| 2009 | 864.5 Million SEK | 0.14% |
| 2008 | 863.27 Million SEK | 7.81% |
| 2007 | 800.77 Million SEK | 0.0% |
| 2006 | - SEK | 0.0% |
| 2005 | - SEK | -100.0% |
| 2004 | 455.86 Million SEK | -7.97% |
| 2003 | 495.33 Million SEK | -1.61% |
| 2002 | 503.41 Million SEK | 22.79% |
| 2001 | 409.96 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 723.83 Million SEK | -19.4% |
| 2023 Q4 | 898.1 Million SEK | 29.4% |
| 2023 Q3 | 694.04 Million SEK | -11.89% |
| 2023 Q1 | 583.73 Million SEK | -19.45% |
| 2023 FY | 2.96 Billion SEK | 26.07% |
| 2023 Q2 | 787.72 Million SEK | 34.94% |
| 2022 Q1 | 484.08 Million SEK | -25.41% |
| 2022 Q3 | 580.29 Million SEK | 3.32% |
| 2022 FY | 2.35 Billion SEK | 20.6% |
| 2022 Q2 | 561.66 Million SEK | 16.03% |
| 2022 Q4 | 724.7 Million SEK | 24.89% |
| 2021 Q4 | 649.02 Million SEK | 36.3% |
| 2021 Q1 | 405.69 Million SEK | -22.9% |
| 2021 FY | 1.94 Billion SEK | 19.4% |
| 2021 Q2 | 418.24 Million SEK | 3.09% |
| 2021 Q3 | 476.17 Million SEK | 13.85% |
| 2020 Q2 | 413.17 Million SEK | 38.23% |
| 2020 Q1 | 298.89 Million SEK | -41.12% |
| 2020 Q3 | 394.16 Million SEK | -4.6% |
| 2020 Q4 | 526.19 Million SEK | 33.5% |
| 2020 FY | 1.63 Billion SEK | -1.73% |
| 2019 FY | 1.66 Billion SEK | 17.52% |
| 2019 Q1 | 332.84 Million SEK | -24.09% |
| 2019 Q2 | 363.26 Million SEK | 9.14% |
| 2019 Q3 | 457.41 Million SEK | 25.92% |
| 2019 Q4 | 507.61 Million SEK | 10.98% |
| 2018 Q1 | 306.06 Million SEK | -21.09% |
| 2018 FY | 1.41 Billion SEK | 11.61% |
| 2018 Q4 | 438.45 Million SEK | 28.34% |
| 2018 Q3 | 341.63 Million SEK | 4.36% |
| 2018 Q2 | 327.36 Million SEK | 6.96% |
| 2017 Q3 | 300.11 Million SEK | -4.24% |
| 2017 Q4 | 387.85 Million SEK | 29.24% |
| 2017 Q1 | 265.12 Million SEK | -22.22% |
| 2017 Q2 | 313.4 Million SEK | 18.21% |
| 2017 FY | 1.26 Billion SEK | 11.01% |
| 2016 Q1 | 230.48 Million SEK | -26.86% |
| 2016 Q3 | 294.21 Million SEK | 6.83% |
| 2016 Q4 | 340.83 Million SEK | 15.85% |
| 2016 Q2 | 275.39 Million SEK | 19.48% |
| 2016 FY | 1.14 Billion SEK | 6.27% |
| 2015 Q1 | 224.86 Million SEK | -16.2% |
| 2015 FY | 1.07 Billion SEK | 11.67% |
| 2015 Q4 | 315.11 Million SEK | 17.18% |
| 2015 Q2 | 264.65 Million SEK | 17.7% |
| 2015 Q3 | 268.92 Million SEK | 1.61% |
| 2014 FY | 961.39 Million SEK | 12.6% |
| 2014 Q1 | 212.43 Million SEK | -21.49% |
| 2014 Q2 | 239.03 Million SEK | 12.52% |
| 2014 Q4 | 268.32 Million SEK | 11.07% |
| 2014 Q3 | 241.59 Million SEK | 1.07% |
| 2013 Q4 | 270.59 Million SEK | 29.12% |
| 2013 Q3 | 209.57 Million SEK | 5.7% |
| 2013 Q1 | 175.34 Million SEK | -29.33% |
| 2013 Q2 | 198.27 Million SEK | 13.08% |
| 2013 FY | 853.79 Million SEK | 4.51% |
| 2012 Q2 | 192.69 Million SEK | 12.72% |
| 2012 Q1 | 170.95 Million SEK | -28.31% |
| 2012 FY | 816.95 Million SEK | -0.75% |
| 2012 Q4 | 248.09 Million SEK | 20.9% |
| 2012 Q3 | 205.2 Million SEK | 6.49% |
| 2011 Q2 | 219.18 Million SEK | 29.45% |
| 2011 Q3 | 196.11 Million SEK | -10.53% |
| 2011 Q4 | 238.47 Million SEK | 21.6% |
| 2011 FY | 823.09 Million SEK | -9.64% |
| 2011 Q1 | 169.32 Million SEK | -19.92% |
| 2010 Q1 | 211.02 Million SEK | -17.97% |
| 2010 Q3 | 236.18 Million SEK | -6.36% |
| 2010 FY | 910.88 Million SEK | 5.37% |
| 2010 Q4 | 211.43 Million SEK | -10.48% |
| 2010 Q2 | 252.24 Million SEK | 19.53% |
| 2009 Q4 | 257.25 Million SEK | 25.57% |
| 2009 FY | 864.5 Million SEK | 0.14% |
| 2009 Q1 | 202.49 Million SEK | 0.0% |
| 2009 Q2 | 199.89 Million SEK | -1.28% |
| 2009 Q3 | 204.86 Million SEK | 2.49% |
| 2008 FY | 863.27 Million SEK | 7.81% |
| 2007 FY | 800.77 Million SEK | 0.0% |
| 2006 FY | - SEK | 0.0% |
| 2005 FY | - SEK | -100.0% |
| 2004 FY | 455.86 Million SEK | -7.97% |
| 2003 FY | 495.33 Million SEK | -1.61% |
| 2002 FY | 503.41 Million SEK | 22.79% |
| 2001 FY | 409.96 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | -47386.092% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | -115.849% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | -115.849% |
| Arcoma AB | 163.01 Million SEK | -1717.997% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | -1352.82% |
| BICO Group AB (publ) | 2.23 Billion SEK | -32.333% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | -418.722% |
| CellaVision AB (publ) | 677.29 Million SEK | -337.567% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | -35722.64% |
| Chordate Medical Holding AB (publ) | 976.28 Thousand SEK | -303460.86% |
| C-Rad AB (publ) | 424.61 Million SEK | -597.952% |
| Duearity AB (publ) | 1.65 Million SEK | -179078.174% |
| Dignitana AB (publ) | 86.06 Million SEK | -3343.532% |
| Episurf Medical AB (publ) | 10.3 Million SEK | -28672.883% |
| Getinge AB (publ) | 31.82 Billion SEK | 90.688% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | -41768.98% |
| Integrum AB (publ) | 104.11 Million SEK | -2746.375% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -346642.771% |
| Mentice AB (publ) | 273.61 Million SEK | -983.15% |
| OssDsign AB (publ) | 112.15 Million SEK | -2542.374% |
| Paxman AB (publ) | 210.11 Million SEK | -1310.456% |
| Promimic AB (publ) | 37.07 Million SEK | -7894.624% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -1214493.033% |
| SciBase Holding AB (publ) | 23.24 Million SEK | -12649.439% |
| ScandiDos AB (publ) | 60.42 Million SEK | -4804.279% |
| Sedana Medical AB (publ) | 153.86 Million SEK | -1826.084% |
| Senzime AB (publ) | 35.75 Million SEK | -8188.882% |
| SpectraCure AB (publ) | 318 Thousand SEK | -931851.887% |
| Stille AB | 294.89 Million SEK | -904.977% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 15.615% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | -395.966% |